MrC's Smallcap Sweeps for July 2020

[MrContrarian]

Smallcap Sweep. 01-Jul-20
Versarien pulls rabbit from hat to offset bad news.

Versarien (VRS) gets £5m Innovate UK loan to significantly increase its manufacture of quality assured graphene. From almost nothing! Aslo, as cynics predicted, Young-Graphene Technology Co fails to cough up for its 50% of JV. VRS buys share for nominal sum. Delays FY accounts to 11 Aug. Neill Ricketts says "We remain well placed in China and the triggering of the backstop arrangement with YG has not fundamentally altered our strategy". Ha, ha.
Kier (KIE) recent Q trading 'resilient' with c.80% of sites remaining open. Almost all sites are now open. Agrees covenant waivers.
Cello Health (CLL) rec cash offer of 161p, a 44% premium.
Wameja (WJA) Mastercard provides €15m Loan Facility to HomeSend to fund pre-payment timing gaps.
Malvern (MLVN) resumes trading on AIM.
VRS also, as cynics predicted, Young-Graphene (Beijing) Technology Co fails to cough up for it's 50% of JV. VRS buys share for nominal sum. Delays FY accounts to 11 Aug. Neill Ricketts says "We remain well placed in China and the triggering of the backstop arrangement with YG has not fundamentally altered our strategy". Super.
Benchmark (BMK) sells veterinary and diagnostic services business FishVet for c £14.5m.
Catenae Innovation (CTEA) covid tracing App ready to be rolled out across the UK and globally, well ahead of schedule. We are receiving enquiries about the app and are in discussions about local and international sales opportunities. I doubt this tinpot has stolen a march on UK Gov't, however easy that may appear.
DP Aircraft (DPA) bust airline Thai Airways will make only interest payments until Sept.
WANdisco (WAND) initial deal worth up to $1m with a major British supermarket. Also strong uptake for Azure Cloud product.
VR Educatio (VRE) MOU with Virtual College, an industry-leading digital learning solutions provider, to provide and deliver technology enhanced learning solutions in the UK and Middle East.
Topps Tiles (TPT) recent week sales £3.9m, down only 5.4% YoY. Does £18.1m sale and leaseback.
OptiBiotix Health (OPTI) non-exclusive distribution agreement with Actial Farmaceutica for distribution of CholBiome and CholBiome-X3 in four new territories in the Asia Pacific.
Bioventix (BVXP) find a CFO.
Lookers (LOOK) suspended due to late finals.
Richland Resources (RLD) cash shell suspended as it fails to make acquisition. Now in late-stage discussions for an RTO.



Notes (do not rely on the data)
VRS: Price=44. Cap=75m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Versarien is engaged in the engineering materials business developing valuable new materials through the commercialization of new manufacturing processes.
KIE: Price=97.55. Cap=158m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Kier Group is a property, residential, construction and services company. It invests in, builds, maintains and renews the places of work, live and play.
CLL: Price=113. Cap=121m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Cello Group with its subsidiary company provides market research and direct communications services to its consumer. Its segments include Cello Health and Cello Signal.
WJA: Price=4.68. Cap=98m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
MLVN: Price=0. Cap=m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Malvern International is engaged in investment holding and provision of educational consultancy services.It provides the educational offering that is broad and geared towards preparing students to meet the demands of business and management.
Beiji: Price=NA. Cap=NA. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
BMK: Price=37.15. Cap=248m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Benchmark Holdings is a drug manufacturer in the United Kingdom. The company caters particularly aquaculture industry with its products such as animal health vaccines, medicines, biocides and diagnostics.
CTEA: Price=2.66. Cap=5m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
DPA: Price=0.14. Cap=30m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
WAND: Price=622. Cap=319m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Wandisco provides collaboration software to software development industry. It offers Active Data Replication, a patented technology that enables replication of continuously changing data to the cloud and on-premises data centres; and WANdisco Fusion.
VRE: Price=16.02. Cap=39m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
TPT: Price=44.4. Cap=87m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Topps Tiles is engaged in the retail distribution of ceramic and porcelain tiles, natural stone, wood flooring and related products. It includes product such as bathroom tiles, kitchen tiles, floor tiles, wall tiles and other tools and essentials.
OPTI: Price=51.8. Cap=46m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
OptiBiotix Health is a life sciences company. The Company through its subsidiaries is engaged in the research and development of microbiome modulators.
BVXP: Price=4150. Cap=216m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Bioventix is engaged in the field of biotechnology. Its business involves the development of high-affinity sheep monoclonal antibodies and clinical diagnostics and drugs of abuse testing.
LOOK: Price=21. Cap=82m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Lookers operates as an automotive retailer & distribution company. The Company along with its subsidiaries is engaged in sale, hire and maintenance of motor vehicles and motorcycles, including the sale of tyres, oil, parts and accessories.
RLD: Price=0.3. Cap=3m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Richland Resources is engaged in mining sapphires at its Capricorn Sapphire mine site in Queensland, Australia. It operates in two segments including Mining and Online sales.

* F/C for prev FY if Prelims released today
Data: yahoo, Google, Morningstar
DYOR, E&OE etc etc. Your sanity may be at risk if you invest in smallcaps. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 02-Jul-20


Air Partner (AIR) continues perform significantly ahead of budget in June, guides U/L pretax at least £10m in first 5 months.
Total Produce (TOT) says H1 'satisfactory' with rev broadly in line YoY. Guides 'satisfactory' FY.
Verditek (VDTK) new orders over the past two weeks in new geographical areas and new vertical markets.
Appreciate (APP) billings down 35% in June, recovering from a low of -70%.
Omega (ODX) antibody test has been approved for testing of COVID-19 in India.



Notes (do not rely on the data)
AIR: Price=85.8. Cap=55m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Air Partner is an aviation charter specialist and an expert in safety consulting and training. The Company offer its services to corporate customers, governments, airlines, defense organizations and aviation authorities.
TOT: Price=96.95. Cap=NA. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Total Produce is acting as a fresh produce provider in Ireland. It is involved in the rowing, sourcing, importing, packaging, marketing, and distribution of an extensive selection of fresh fruits, vegetables, and flowers.
VDTK: Price=8.25. Cap=24m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Verditek through its subsidiaries is engaged in solar photovoltaic, filtration and absorption technologies specialising in providing environmental services.
APP: Price=27.6. Cap=51m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
ODX: Price=40.7. Cap=64m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Omega Diagnostics Group provides in-vitro diagnostics (IVD) products for use in hospitals, blood banks, clinics and laboratories and specializes in the areas of allergy and autoimmune, food intolerance and infectious diseases.

* F/C for prev FY if Prelims released today
Data: yahoo, Google, Morningstar
DYOR, E&OE etc etc. Your sanity may be at risk if you invest in smallcaps. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 03-Jul-20
Will Foot fit SHOE?

Shoe Zone (SHOE) FD scarpers. He is thanked and new one appointed - Peter Foot.
Farcejet (FJET) co will continue to have sufficient resources to meet its operational needs until the end of Aug."If flight operations do not restart to sustainable levels by the beginning of September or the Company is unable to access hard currency from the Reserve Bank of Zimbabwe through repayment against the Company's historical legacy loans, it will cease to be a going concern."
Amigo (AMGO) agrees with FCA to handle all complaints within 8 weeks by Oct. Compensation & handling cost is expected to be substantially higher than the estimate of at least £35m. Cash at hand £136m.
Capital & Regional (CAL) received or expect to imminently receive 34% of rent due in June. Several of the non payers have engaged with us regarding payments now stores are trading. Cash at hand £81m, over a year's rev. Paused commitments to the proposed Hemel Hempstead Leisure project.
Catenae Innovation (CTAE) has finalised the development of a new product 'Onsite ID', a generic multi-document digital wallet. Dev was slowed during dev of the headline-grabbing, er possibly world-beating, covid tracking app.
Trakm8 (TRAK) as trailed in Apr, wins 2 year fleet optimisation contract with a major UK food retailer that had been expected in March. No £££.
Numis (NUM) Q3 rev materially ahead of each of the first two Qs. Guides H2 rev and and profits up on H1.
Arena Events (ARE) FY (15 months) rev up 36% (19% in comparable last 12 months) and adj EPS -3 (+3.7). Passes div. Outlook extremely challenging.
Manolete Partners (MANO) FY(March) dil EPS up 70% to 17p. Final div 3p (1.49p). Outlook "With a far greater number of cases (and generally larger cases) either recently completed or in progress, the outlook for further increased material cash generation from the portfolio appears very encouraging."

In line: APTD

Notes (do not rely on the data)
SHOE: Price=80. Cap=40m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Shoe Zone is a UK based company operates as a footwear retailer. It offers low cost footwear with high quality in wide range and variety for all ages.
FJET: Price=0.16. Cap=6m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
FastJet provides airline services. It is a holding company for a low-cost airline which operates flights under the fastjet brand in Tanzania using a fleet of three Airbus A319 aircraft.
AMGO: Price=8.5. Cap=40m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
CAL: Price=84.8. Cap=95m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Capital & Regional is a UK focused specialist property real estate investment trust. It wholly owns and manages shopping centers situated in Blackburn, Camberley, Hemel Hempstead, Luton, Maidstone, Walthamstow, and Woodgreen.
CTAE: Price=NA. Cap=NA. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
TRAK: Price=17.7. Cap=9m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Trakm8 Holdings is a UK based Big Data company. The company through its subsidiaries is engaged in manufacturing, marketing, and distribution of vehicle telematics equipment and services.
NUM: Price=312. Cap=330m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Numis Corp is a United Kingdom-based company that offers investment banking and stock broking services to corporate and institutional clients in the United Kingdom and the United States.
ARE: Price=6.67. Cap=17m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Arena Events Group is an event design and delivery company providing temporary physical structures, seating, ice rinks, furniture, and interiors. The company serves sporting, outdoor and leisure events in Europe, the US, the Middle East and Asia.
MANO: Price=515.6. Cap=225m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.

* F/C for prev FY if Prelims released today
Data: yahoo, Google, Morningstar
DYOR, E&OE etc etc. Your sanity may be at risk if you invest in smallcaps. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 06-Jul-20
Part 1/2.

Gunsynd (GUN) £465k placing at 0.65p, a 7% disc.
boohoo (BOO) strong response to Sunday Times exposure of alleged supplier malpractices.
BigDish (DISH) expands scope of business from discount app to 'a complete dining solution for restaurants and consumers', as if that was possible. Will scrap commission and charge monthly fee. There is probably a reason no other co does this. Good luck to them. Will offer food delivery app and a Super App - many apps within an umbrella app.
ValiRx (VAL) new corporate strategy for tinpot co - "will build on its existing portfolio of drug candidates and grow a pipeline of innovative, early-stage projects in the areas of oncology and women's health..."We've shifted the development paradigm for ValiRx to earlier in the drug discovery process. This is intended to maximise the impact that our intellectual and financial contribution can make."
Urban Logistics (SHED) 98% of Q rent has been collected.
Gresham Technologies (GHT) guides H1 rev down 2%. Recent orders mean mgmt confident will hit FY guidance for adj EBITDA and 'Cash' EBITDA.
Dev Clever, (DEV) partnership agreement with Veative Labs, a leading provider of online and immersive learning modules within the EdTech sector. Will "creates a fully comprehensive remote e-learning solution."
Zoetic (ZOE) first international distributor for its Chill brand of tobacco alternative CBD products, for Czech Republic and Slovakia. JV with former COE ended, co claims transitional period has now concluded. UK operations will remain uninterrupted with no change to the fulfilment of online sales of the 21 existing product lines.
Filtronic (FTC) wins 2 year £4.9m order, delivery starting Aug.
UP Global Sourcing (UPGS) guides FY above mkt expectations with rev over £111m and U/L pretax above £7.4m.
Collagen Solutions (COS) a euphemistic 'Realignment of Bond Repayments' - a reduction in capital repayments and a delay to the final repayments.
Cohort (CHRT) wins 2 year £20m order, delivery starts in FY21 H2.
Concepta (CPT) relaunches MyLotus fertility fertility tracking and pregnancy self-testing system. Renames it and will sell online. Marketing campaign. Has it bombed? Claims 5k app downloads but no fig for paying users. Also 30% cost reduction to the current operating overhead with more to come.
Mobile Streams (MOS) in an RNS that misspells its own name, launches an SaaS Insight platform. Over 30 launch partners signed up. "SaaS Platform has been designed to provide ease of use, simple access, and price points that focus on small/medium business and individuals looking to gain insight for their digital marketing strategies."
Fusion Antibodies (FAB) has commenced its proof-of-concept work on the Mammalian Antibody Library Discovery Platform. Also hits first milestone in covid associated project, with the synthesis of the antibody library DNA. CEO trumpets "excellent progress on the launch of the proof-of-concept for the Mammalian Library and have generated a panel of SARS-CoV-2 S antigens." Antigens? Is that in addition to the antibody library?
Sabien Technology (SNT) H2 rev 2x H1 but FY still down due to covid and an exceptional order last year. "Board believes that first half sales represent a "low watermark" after several years of diminishing performance by the previous Board...Sabien is planning a strong start to the new financial period with a backlog of more than 300 M2G units to install and a confirmed order book of approximately £140k."



Notes (do not rely on the data)
GUN: Price=0.72. Cap=1m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Gunsynd is an investment company. The company's investing policy is to invest in and/or acquire companies and/or projects within the natural resources sector.
BOO: Price=387.5. Cap=4878m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
boohoo.com is an online fashion retailer catering men and women in the UK and internationally. The firm designs, markets and sells its own-brand products through its website www.boohoo.com. Its business is spread across the UK, Europe and Others.
DISH: Price=2.7. Cap=10m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
VAL: Price=7.71. Cap=3m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
ValiRx is a biopharmaceutical company. The Company is engaged in developing technologies and products in oncology therapeutics and diagnostics focused on the treatment of cancer and associated Biomarkers, specializing in epigenomic & genetic analysis.
SHED: Price=135.2. Cap=259m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
GHT: Price=128. Cap=88m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Gresham Technologies is a software services company providing a real-time transaction control and enterprise data integrity solutions. The company operates in two reportable segments; Clareti Solutions and Other Solutions.
DEV: Price=6.85. Cap=32m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
ZOE: Price=8.6. Cap=17m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
FTC: Price=7.5. Cap=18m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Filtronic designs and manufactures broadband microwave and base station filter products for wireless telecommunications systems. Its products include wireless communication equipment and point-to-point communication systems.
UPGS: Price=67.6. Cap=56m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
UP Global Sourcing Holdings develops, designs, sources and distributes consumer products. The Company focused on six product categories including SDA, Housewares, Audio, Laundry, Heating & Cooling and Luggage.
COS: Price=3. Cap=13m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Collagen Solutions is a supplier, developer, and manufacturer of collagen-based biomaterials and medical devices, including tissue scaffolds for use in regenerative medicine. The company derives most of its revenue from North America.
CHRT: Price=509. Cap=217m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Cohort through its subsidiaries provides technology business services and products for the United Kingdom and international customers in defense and related markets. The company’s operating segments are MASS, MCL, SCS, and SEA.
CPT: Price=1.11. Cap=6m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Concepta is engaged in health diagnostics for women's fertility and specifically unexplained infertility. Concepta's portfolio of products includes MyLotus Meter, Ovulation Test, Pregnancy Test and Fertility App.
MOS: Price=0.26. Cap=3m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Mobile Streams is engaged in the sale of mobile content through Multi-National Organisation's, the sale of mobile content over the internet and the provision of consulting and technical services.
FAB: Price=97.5. Cap=26m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Fusion Antibodies is engaged in the research, development and manufacturing of recombinant proteins and antibodies, particularly in the areas of cancer and infectious diseases.
SNT: Price=0.19. Cap=3m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Sabien Technology Group is engaged in designing, manufacturing and sale of M2G, a boiler energy efficiency technology to reduce energy consumption on commercial boilers by up to 35%.

* F/C for prev FY if Prelims released today
Data: yahoo, Google, Morningstar
DYOR, E&OE etc etc. Your sanity may be at risk if you invest in smallcaps. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 06-Jul-20
Part 2/2

Macfarlane (MACF) Q2 better than expected with rev down only 7%. Guides FY profit and staying well within the current borrowing facility.
N4 Pharma (N4P) optimisation programme progress slower than originally hoped. Also Evotec remains on track with the in vitro testing of Nuvec loaded with the Covid plasmid. Also "recent research on Nuvec indicates that its unique spiky structure could give it a significant competitive advantage as a potential delivery system for use in oral vaccines."
UAE Oil Services (UOS) exec chmn scarpers 'in order to focus on other projects'. He is not thanked.



Notes (do not rely on the data)
MACF: Price=77.6. Cap=122m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Macfarlane Group is engaged in the designing, manufacturing and distribution of protective packaging products and labels to business users. The company operates in two segments including Packaging Distribution; and Manufacturing Operations
N4P: Price=4. Cap=6m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
N4 Pharma is a specialist pharmaceutical company which reformulates existing drugs and vaccines to improve their performance. Its vaccines include Nuvac and Nuvec.
UOS: Price=700. Cap=NA. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.

* F/C for prev FY if Prelims released today
Data: yahoo, Google, Morningstar
DYOR, E&OE etc etc. Your sanity may be at risk if you invest in smallcaps. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 07-Jul-20


Renewi (RWI) Q1 ahead of initial Covid-19 adjusted expectations with earning hit €8m less than guided. "We remain alert to the potential for a decline in late cycle activities such as construction."
Seeing Machines (SEE) US House votes for bill that will set to mandate DMS from 2024. Still needs Senate and Presidential approval. But Euro NCAP delays the '2022 and 2024 rating', co does not expect any material impact to near-term forecast for Automotive revenue.
Sosandar (SOS) Q1 rev up 54%, loss down c.70%. Also June neared breakeven. Plans to ramp up marketing spend towards the end of Q2. Cash down only slightly in May & June.
Reach (RCH) cost cutting and job losses ('transformation to accelerate customer value strategy') after Q2 rev falls 27.5%. June down 24%. Cuts to save £35m PA. Customer registration target increased to 10m by 2022 (was 7m).
Velocity Composites (VEL) new framework agreement to 2022 with an existing customer. No £££.
Live Company Group (LVCG) wins 2 contracts. Q2 poor but no nos. Cost cutting & job losses.
RDI REIT (RDI) June Q rent collection 70%, up from 54% in March. Cash at hand £80m.
LPA Group (LPA) £3.3m contract wins in rail mkt. Majority of output expected through next FY.
Altitude (ALT) trading in line. "Subject to continued steady recovery in transactional volume through 2020 in the promotional products market, we believe the Company has sufficient financial resources and liquidity to see the business through to more normalized market conditions."
SkinBioTherapeutics (SBTX) progress on this and that but no mention of sales. Cash £2.1m down £0.4m in half.
Avingtrans (AVG) guides FY(May) rev £114m up 9%, adj EBITDA at least £11.5m (£9.4m). Order book and prospect pipeline remains strong overall but some reduced prospects in specific sectors, notably in O&G. Credit headroom over £10m. Two new nuclear sector contract wins worth £6.4m.

In line: PCIP

Notes (do not rely on the data)
RWI: Price=25.95. Cap=208m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Shanks Group is a waste-to-product company providing services such as collection, recycling and treatment of commercial waste, reprocessing and recycling of contaminated soil and materials.
SEE: Price=3.38. Cap=114m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Seeing Machines provides operator monitoring and intervention sensing technologies and services for the automotive, mining, transport and aviation industries. It develops products to detect and manage driver fatigue and distraction.
SOS: Price=10.35. Cap=20m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Sosandar is an online women's wear brand specifically targeted at a generation of women who have graduated from younger online and high street brands, and are looking for affordable clothing with a premium, trend-led aesthetic.
RCH: Price=88.8. Cap=266m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
VEL: Price=16. Cap=6m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Velocity Composites is a manufacturer of advanced carbon fibre and ancillary material kits for use in the production of aircraft. It offers structural material kits, engineering vacuum bag material kits, and process optimisation products.
LVCG: Price=10.1. Cap=9m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Live Co Group is engaged in live music and entertainment events. It operates through two segments Events, and Issuing licences.
RDI: Price=79.9. Cap=304m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
LPA: Price=61. Cap=8m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
LPA Group is engaged in designing, manufacturing & supplying LED based lighting & electro-mechanical systems and also distributes engineered components for rail, infrastructure and aviation; and aerospace & defence markets.
ALT: Price=28.15. Cap=20m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Altitude Group operates a technology and information business in the UK and across North America with a focus on serving the promotional merchandise, marketing services and print sectors.
SBTX: Price=16.88. Cap=22m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
SkinBioTherapeutics is a life science company. The company is engaged in the development of technology to protect, manage and restore skin utilising proteins found in human microbiota.
AVG: Price=232. Cap=74m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Avingtrans is engaged in providing engineered components, products, systems and services to the energy, medical and traffic management industries internationally.

* F/C for prev FY if Prelims released today
Data: yahoo, Google, Morningstar
DYOR, E&OE etc etc. Your sanity may be at risk if you invest in smallcaps. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 08-Jul-20


e-therapeutics (ETX) last night - 12p placing (31% disc) to raise £12.4m max o expand platform capabilities and asset pipeline.
Zoetic (ZEO) has to sweeten the deal a little on the sale of its DT Ultravert Interest and Kansas Nitrogen Assets.
Eurocell (ECEL) guides H1(June) rev down 31%. Since re-opening, sales have exceeded mgmt expectations.
Medica (MGP) guides H1(June) rev down 22% due to the impact of covid on radiology reporting activity, as previously announced. Co has not required any government funding or furloughed staff. Capacity has strengthened and recruitment has been strong.
Funding Circle (FCH) since getting UK approval late Apr co has approved c.£460m of applications through the CBILS programme and originated c.£300m. In US co has approved c.$800m and originated c.$300m in covid scheme. Will make a write-down in warehouse-backed bonds, amount TBD.
Distil (DIS) Q1(June) rev up 21% with volume flat (due the loss of licensed sales of Blavod Black Vodka in Duty Free and Travel Retail throughout April to June). H1 guidance is for 75 - 85% rise. Co does not necessarily anticipate these levels of increase to continue throughout the full year. Will boost prod dev and ad spend.
MaxCyte (MXCT) sells APN401 license: non-exclusive clinical and commercial rights to use MaxCyte's Flow Electroporation techn and ExPERT platform for the advancement of APN401, a cell therapy currently in clinical development for various solid tumors. Co gets development and approval milestones and sales-based payments in addition to other licensing fees. No £££.
Iconic Labs (ICON) wins management services contract with Greencastle which has bought JOE media UK business out of administration. The JOE media businesses have £10m rev. This will enable Iconic Labs to become operationally profitable within three months.
Mpac (MPAC) H1(June) update: co continues to win original equipment and service orders. Order book £45.4m (£39.9m). Cash at hand £23m, up £4.1m during half.
Cohort (CHRT) wins Joint Command and Staff Training contract for UK Strategic Command. Worth £11m over 2 years.
boohoo (BOO) acts to sort out crisis: immediate independent review of supply chain, £10 million to eradicate supply chain malpractice and accelerate independent third party supply chain review with ethical audit and compliance specialists, Verisio and Bureau Veritas. Refutes some of the allegations. "Our investigation to date has not found evidence of suppliers paying workers £3.50 per hour. However we have found other evidence of non-compliance with our Code of Conduct and the Group has taken the decision to immediately terminate its relationship with both suppliers." Why not before?

In line: DXRX

Notes (do not rely on the data)
ETX: Price=17. Cap=55m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
e-Therapeutics is a drug discovery company. The company's discovery platform is based on the network of pharmacology and chemical biology. e-Therapeutics operates in a single business segment of drug discovery and development.
ZEO: Price=NA. Cap=NA. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
ECEL: Price=164. Cap=182m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Eurocell is the UK's leading manufacturer, distributor, and recycler of Unplasticized PVC (UPVC), a type of building plastic. Its products include UPVC windows, doors, conservatories, skylights, roofs, and roofline systems.
MGP: Price=120. Cap=134m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Medica Group is a provider of teleradiology services. Teleradiology is the electronic transmission of radiological patient images, including plain film x-rays, Computerised Tomography scans and Magnetic, Resonance Imaging scans.
FCH: Price=70. Cap=244m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
DIS: Price=1.01. Cap=5m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Distil is engaged in the marketing and selling of Blavod Black Vodka, Blackwoods Gin, and Vodka, Diva Vodka, Jago's Vanilla Cream Liqueur and RedLeg Spiced Rum domestically and internationally.
MXCT: Price=198.5. Cap=132m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
MaxCyte Inc is a provider of technological solutions to pharmaceutical companies. Its key product is electroporation technology which is sold to companies which are engaged in drug discovery and development.
ICON: Price=0.01. Cap=1m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
MPAC: Price=242.2. Cap=49m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
CHRT: Price=551. Cap=226m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
Cohort through its subsidiaries provides technology business services and products for the United Kingdom and international customers in defense and related markets. The company’s operating segments are MASS, MCL, SCS, and SEA.
BOO: Price=261.4. Cap=3291m. F/C for current FY*: EPS= NA, Prospective PE= NA, Revenue=NA.
boohoo.com is an online fashion retailer catering men and women in the UK and internationally. The firm designs, markets and sells its own-brand products through its website www.boohoo.com. Its business is spread across the UK, Europe and Others.

* F/C for prev FY if Prelims released today
Data: yahoo, Google, Morningstar
DYOR, E&OE etc etc. Your sanity may be at risk if you invest in smallcaps. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 09-Jul-20

Note new format: the long appendix dropped, SP & cap follows each summary.

EQTEC (EQT) £10m placing and PrimaryBid offer at 0.45p, a 33% discount, to repay loans, product dev and working cap. [SP=0.5 Cap=22m]
DWF Group (DWF) recent 2 months rev and EBITDA ahead of budget and prior year. Rev up 21%, 6% organic. EBITDA up by c. £3m. [SP=58 Cap=188m]
Ceres Power (CWR) last 12 months (extended interim) to June rev c. £20 million, up 20-25%. Expects to sign new customer partnerships in H2. [SP=604.2 Cap=1042m]
Telit Communications (TCM) guides H1(June) EBITDA and profit in cash up. Rev down 8%. "Although it is now likely that revenues [cont] for the full year will be below those of the previous financial year the Group still expects to meet board expectations for both Adjusted EBITDA and Profit in cash." [SP=122 Cap=161m]
Escape Hunt (ESC) all 8 venues in England will reopen on Sat. [SP=7.74 Cap=6m]
Charles Stanley (CAY) Q1(June) rev up 1.7% with fee income up 4% and interest income down 38%. [SP=250.6 Cap=128m]
Science in Sport (SIS) guides H1(June) rev down 5%. Cash at hand £9m. No FY guidance. [SP=31.85 Cap=43m]
NewRiver REIT (NRR) In retail 81% of occupiers by gross income are now open. 46% of Q rent has been collected and 25% have alternative payment terms agreed. Over 90% of co's community pubs in England have now reopened. Operator managed pubs LFL sales up 4%. [SP=62.77 Cap=193m]
IMImobile (IMI) Q1(June) gross profit up c. 20%, net cash of £2m following placing. This underpins confidence in achieving good year-on-year gross profit growth. [SP=946.95 Cap=2616m]
Dev Clever (DEV) launches PubPal, a mobile and contactless ordering and payment service to support the independent hospitality sector. It doesn't require clients to download a mobile app. Co takes a commission. Sounds useful but will it be taken up? Are there rivals? [SP=7.6 Cap=33m]
Deltex Medical (DEMG) guides H1 rev down 30%. Covid sales spike has gone. Co has started to see a resumption in sales in the US and to its international distributors. Cash at hand only £0.6m, down £0.3m in H. "Given the potential activity levels associated with pent-up demand associated with elective surgery, it is at the moment too early to predict what the outcome will be for the full year and a further update will be provided at the time of the Group's interim results." [SP=1.49 Cap=8m]
Spectra Systems (SPSY) Contract for enhanced counterfeit banknote detection with a major central bank. Dev phase worth $521k, second phase is $175k max option. [SP=138.99 Cap=57m]
RBG Holdings (RBGP) guides H1(June) fees at main subsidiary Rosenblatt up 38%. "While the Group continues to enjoy a strong pipeline of opportunities, the Board notes that it is not certain that this rate of growth will continue in H2". No revenues from Litigation Finance but co has approved and expects to execute four potentially significant commercial litigation financing transactions imminently. Convex Capital has had nearly all transactions planned for H1 deferred. Not clear how many will be executed in H2. No FY guidance. [SP=70 Cap=60m]
Robert Walters (RWA) guides Q2(June) in line with net fee income down 34% (at const currency). [SP=400 Cap=304m]
Tracsis (TRCS) recent lockdown trading better than originally expected. Guides FY rev £46m with estimated £10m covid hit. "We continue to deliver a number of large multi-year projects whilst winning new work and have a good pipeline of future opportunities." [SP=610 Cap=178m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 10-Jul-20
Busy for Friday.

SRT Marine Systems (SRT) Philippines fisheries management system project has recommenced, with a significant cash payment received. Final contract negotiations have recommenced in the ME. Transceivers business sales up 2% in Q1, ahad of expt. [SP=33.25 Cap=56m]
Inspired Energy (INSE) £30m placing and £5m OO at 15p a 13% disc. Cash needed for o fund the initial cash consideration for the Acquisition and to provide additional financing to fund further acquisition opportunities to accelerate the Company's growth strategy in ESG. [SP=16.32 Cap=120m]
Restaurant Group (RTN) £50m covid loan. amended Revolving Credit Facility with facility cut by £40m. Outlet reopening will be gradual. [SP=54.85 Cap=331m]
Focusrite (TUNE) rev and profit ahead of mgmt expt so 'likely' to beat FY(Aug) mkt expt. [SP=680 Cap=395m]
Tanfield (TAN) 49% owned Snorkel's FY(Dec) rev up 10% but EBITDA -$0.1m (+$3m). Snorkel mgmt stalled on supplying figs a and refuse to explain hike in costs that caused EBITDA loss. [SP=2.5 Cap=6m]
Infrastrata (INFA) £9m placing at 0.35p, a 10% disc to strengthen balance sheet, enable it to tender for and win larger contracts, pay deferred consideration for the Harland & Wolff and pay down smaller bridging loans and the redemption of redeemable prefs. [SP=0.34 Cap=13m]
Gym Group (GYM) phased re-opening gyms in England from 25 July. [SP=158 Cap=262m]
Senior (SNR) guides H1(June) rev down 30% and margins will be significantly lower. Net cash inflow of £3m. Accelerated restructuring plan, charge to be up to £35m (from £23m) with cash cost up to £25m (£15m). Not anticipating meaningful improvement in our end markets for Flextronics in H2. [SP=60.6 Cap=232m]
International Personal Finance (IPF) June net cash flow £42m (May: 43m). Collections effectiveness continued to improve in June, reaching 88% of pre-Covid expectations. Lending in June was 37% of pre-Covid expectations up from 30% during both of April and May. [SP=51.9 Cap=123m]
Litigation Capital Management (LIT) consistent performance in recent months. Asmall number of Australian investments have now been pushed into next FY: rev hit but "effect on earnings is minimal which reflects proportionate cost control." [SP=57.2 Cap=66m]
InnovaDerma (IDP) guides FY(June) rev up 2% but profit will be 'much-reduced' due to higher on-line advertising costs, lower margins of DTC product bundles and shop closure. The cost of advertising on Facebook rose suddenly and sharply in the last quarter. Net cash c.£1.3m. [SP=55 Cap=8m]
IQ-AI (IQAI) commenced development of a cancer imaging technology that will detect cancer cells before they are visible on standard MRI. [SP=3.73 Cap=4m]
Genedrive (GDR) guides FY(June) rev in line at £1m. Has signed additional distribution contracts in 11 countries. Has over £1.0m of indicative orders for covid test but needs regulatory approvals to ship which are taking longer than anticipated. A point of care test for covid remains targeted for the end of 2020. [SP=85 Cap=47m]
Impact Healthcare REIT (IHR) collected all rent for Q. [SP=96.78 Cap=309m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 13-Jul-20
QUIZ has questions to answer

Modern Water (MWG) Integumen and Avacta intend to enter into a supply agreement for the supply of Affimers into Integumen's sensors with the aim of integrating these sensors and retrofitting them into Modern Water's Microtox water contamination system units to detect covid. Awaits testing of Avacta Affimer reagents is completed over the next few weeks. [SP=2.18 Cap=11m]
Global Ports Holding (GPH) has suspended its pursuit of a Premium Listing on the LSE. Also will terminate the Relationship Deed with its controlling shareholders, Global Ports Holding B.V. and Global Yatırım Holding to allow the co to benefit from more efficient sharing of its controlling shareholders' resources. [SP=73.8 Cap=46m]
EQTEC (EQT) Aries Clean Energy filed a complaint in a Californian court against the co and others, alleging patent infringement through the use of the Group's advanced gasification technology in the North Fork Community Power project. Applies to USA only. Co says claim without merit. [SP=0.38 Cap=16m]
Morses Club (MCL) launches remote lending process for new home collect credit customers. [SP=55.7 Cap=73m]
Ethernity Networks (ENET) £780k placing at 12p, a discount of 37%, to keep the lights on. [SP=19.2 Cap=6m]
DeepMatter (DMTR) £2.1m placing at 1.5p, a 19% discount, to strengthen the balance sheet and invest in sales, marketing, distribution and support. [SP=1.51 Cap=11m]
Alternative Income REIT (AIRE) issues confusing set of nos for Q rent collection. [SP=50.84 Cap=41m]
Luceco (LUCE) guides H1 rev down 14% but adj op profit up 25%. guides FY adj op profit at least flat and ahead of current analyst expectations. Co not making use of any government lending or tax deferral schemes. [SP=129.82 Cap=209m]
Image Scan (IGE) partnership agreement with a major security technology company that will lead to the launch of a new range of security X-ray screening systems [SP=2.29 Cap=3m]
Intelligent Ultrasound (MED) guides H1 rev £2.5m (£3.1m). Lockdown has dramatically constrained the Group's ability to demonstrate and therefore sell ultrasound training simulators to hospitals. [SP=10.95 Cap=29m]
Quiz (QUIZ) fingered by press in Leicester rag trade scandal. "From our initial review, we believe that one of QUIZ's suppliers based in Leicester has used a sub-contractor in direct contravention of a previous instruction." [SP=6.34 Cap=8m]
Corero Network Security (CNS) guides H1 rev up 48% and order intake up 58%. Co "continues to invest in sales and marketing, with progress achieved against its strategy to both augment its direct sales efforts and increase momentum through its channel partners in more regions." [SP=8.37 Cap=41m]
Avacta (AVCT) see Modern Water announcement. [SP=116.38 Cap=290m]
Integumen (SKIN) see Modern Water announcement. [SP=1.93 Cap=21m]
Directa Plus (DCTA) wins contract to supply total waste management services to Cummins Generator Technologies in Romania. Worth $3m over 3 years starting Oct. [SP=75.5 Cap=46m]
Novacyt (NCYT) guides H1 rev up over 900% to €72.4m. Demand for the Company's COVID-19 test remains strong with some extended into the second half of the year and in some cases into 2021. Guides H2 rev better than H1. [SP=283 Cap=221m]
Remote Monitored Systems (RMS) £265k placing at 0.25p, an 11% premium, to keep the lights on. [SP=0.21 Cap=1m]
Nanoco (NANO) gets litigation funding for patent case against Samsung. [SP=20.65 Cap=59m]
Clinigen (CLIN) Orphan Drug Designation for aldesleukin in the treatment of Amyotrophic Lateral Sclerosis, a severe neurodegenerative disease leading to progressive muscle weakness, paralysis and death within a median time of 2-4 years. Needs marketing approval for this indication. [SP=790.2 Cap=1050m]
Westminster Group (WSG) guides H1 rev up 24% and a move into profit. [SP=10.63 Cap=17m]
Northern Bear (NTBR) FY(Mar) rev down 3%, adj EPS 8.7p down 36%. Passes div. Back to 75% of normal activity levels. Order book has continued to increase. [SP= Cap=]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 14-Jul-20
Part 1/2

EKF Diagnostics (EKF) guides H1 rev £26.3m, adj EBITDA £9m, beating May guidance of of at least £25m and £7.5m resp. It's largely due to high demand for the PrimeStore MTM Device which is used for safe covid sample collection. Expects H2 to continue this momentum. [SP=44 Cap=200m]
DFS Furniture (DFS) guides FY(june) rev down 27%, pretax -£56-58m excluding Sofa Workshop and Dwell restructuring costs. Order intake 1 June and 12 July up 69% but remains cautious for remainder of 2020 and into 2021, given likely lower consumer confidence and a potentially slower residential property market. [SP=155 Cap=396m]
Elecosoft (ELCO) guides H1(June) rev down 4% but adj pretax up 14%. [SP=78.7 Cap=65m]
Somero Enterprises (SOM) guides H1 rev in line. Net cash at least $28m cf pre guidance $24m. Outlook - too soon to say. [SP=229 Cap=129m]
City of London Investment Group (CLIG) guides FY(June) FuM up 2% on $. [SP=395 Cap=105m]
McBride (MCB) guides FY(June) adj pretax ahead of current market consensus of £21.6m. [SP=60 Cap=110m]
Netcall (NET) guides FY(June) in line with market expectations: rev up 10% and adj EBITDA up c. 29%. Net cash ahead of exp. "Board anticipates that the disruptions caused by the pandemic will accelerate organisations' digital transformation initiatives." [SP=36.22 Cap=52m]
Mattioli Woods (MTW) guides FY(May) profit in line with prev guidance. CFO resigns, becomes Chief Strategic Adviser. [SP=718.75 Cap=194m]
Brand Architekts (BAR) guides FY(June) rev-cont down 17%, better than April's guidance. Outlook "there is still a great deal of uncertainty surrounding the impact of COVID-19 on the wider economy and consumer confidence, we expect this will continue into the first half of FY21, with some improvement in the second half." [SP=114 Cap=20m]
Filta Group (FLTA) AGM stmt: June rev up 38% on May. Co has been cash generative Jan-June. Expects revenue trend seen in late Q2 to continue into Q3. [SP=100 Cap=29m]
Bango (BGO) guides H1(June) rev up over 50%, adj EBITDA above whole of prev FY. [SP=163 Cap=121m]
Manolete Partners (MANO) long refutation of bear note published on Friday since when SP has fallen 15%. [SP=410 Cap=179m]
IQGeo (IQG) guides H1(June) rev up 11% and orders up over 100%. Outlook "IQGeo sees continued market demand reflecting the fact that both telecoms and utilities markets have been less affected than other sectors." [SP=60 Cap=30m]
Clinigen (CLIN) guides FY(June) rev up at least 13% and 17% at const currency. Adj EBITDA up at least 29%. Outlook "We continue to see organic growth in line with our medium term guidance at this early stage of the new financial year, despite COVID-19 and expected competitive pressure to Foscavir. As we look beyond FY21, we see growth significantly accelerating as we onboard new asset Erwinase and we continue to gain share in the end-markets we serve." [SP=795 Cap=1057m]
Vertu Motors (VTU) June trading stronger than co expected with adj pretax £9.0m. Cash position was "much stronger than we could have hoped". Will make 6% of staff redundant. No FY guidance. [SP=22.7 Cap=84m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 14-Jul-20
Part 2/2

Futura Medical (FUM) submits MED3000 (erectile dysfunction treatment) product dossier for review to EU body. FDA however needs additional clinical efficacy data beyond the Company's three months' home use study. Holders have been waiting forever for this to come good. [SP=15.74 Cap=39m]
Connect Group (CNCT) guides FY adj pretax-cont £26-28m (pre-IFRS16 lease adjustments). Newspaper sales in the 15 weeks to 4 July 12% lower than the equivalent period pre-lockdown. Mags 18% down. [SP=18.49 Cap=46m]
DX (DX.) June rev 3% below pre-covid exp. Guides FY(June) revenue and adjusted EBITDA in line. [SP=16 Cap=92m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 15-Jul-20
Electric SUV racing is no joke.

Capital Limited (CAPD) guides H1 rev up 19% as gold price boosts mining. Outlook "encouraging signs of improvement in the [lockdown] situation, with the resumption of smaller exploration projects and easing of some travel restrictions" [SP=61.99 Cap=85m]
Arcontech (ARC) guides FY(June) profit in line. [SP=158.06 Cap=21m]
Finsbury Food Group (FIF) guides FY(June) rev down 3%. with steady monthly improvement during Q4. Net debt down 24% to c.£27m. Outlook "barring a significant return to lockdown, the Group anticipates a gradual recovery as consumers readjust shopping and consumption behaviours both in and out of home." [SP=59.69 Cap=78m]
Air Partner (AIR) AGM stmt: 5 months to June significantly ahead of budget with U/L pretax at least £10m. Trading in July has been more normalised. Visibility for the second half remains limited, with economic and regulatory uncertainty from the impact of covid. Enters Australian market through its security business Redline to develop and deliver a Security Management System for ISS Australia and New Zealand. [SP=97 Cap=62m]
BATM Advanced Communications (BVC) launches three new diagnostic kits to significantly advance the diagnosis of COVID-19 and other respiratory illnesses. Includes improved antibody test that measures quantity, not just presence. Expects to commence sales and production of the kits around end Sept. [SP=125.5 Cap=553m]
Allergy Therapeutics (AGY) guides FY(June) earnings above market expectations, partly thanks to delaying R&D. Rev up 6%. Will repay furlough monies. [SP=13.68 Cap=87m]
Carr's Group (CAR) trading in line. Will pay interim div of 2.25p. [SP=9.4 Cap=7m]
AFC Energy (AFC) to supply zero emission, hydrogen fueled, off-grid power to Extreme E's groundbreaking inaugural electric SUV racing series in early 2021. Just PR and for a pointless race format at that. What next, clockwork wheelbarrow hurdles? [SP=23.2 Cap=133m]
Mission Group (TMG) trading ahead of initial projections at the outset of the pandemic with H1 rev £29m (£39m) and pretax -£2.2m (+£3.4m). Short-term outlook remains uncertain. [SP=63.1 Cap=57m]
MaxCyte (MXCT) guides H1 rev up 30%. Outlook 'confident'. [SP=221 Cap=147m]
Hydrogen (HYDG) guides H1(June) net fee income down 34%. Net cash up £2m in half to £6.5m. [SP=31.9 Cap=11m]
Alpha FX (AFX) guides H1(June) rev up 16%. [SP=680 Cap=272m]
Portmeirion (PMP) guides H1(June) rev down 8% and LFL down 20%. Expect a ow single digit £ million loss (£0.5m profit). Outlook "We are currently seeing good order intent from customers for our key seasonal trading period and assuming no further Covid-19 disruption and the trend of improved month on month trading continues, we are confident that we will return to profitability in H2." [SP=354 Cap=49m]
Woodbois (WBI) £13.1m placing & PrimaryBid offer at 2p, a 37% discount, last night. [SP=3.2 Cap=15m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 16-Jul-20


Aseana Properties (ASPL) revised timetable for demerger - vote in Aug. Four Points Sheraton Hotel in Sandakan permanently closed after Marriott terminates mgmt of it, along with a number of other hotels that they manage in Asia. [SP=0.37 Cap=66m]
Tiziana Life Sciences (TILS) has submitted a patent application on potential use of Foralumab, a fully human anti-CD3 monoclonal antibody, to improve success of CAR-T therapy for cancer and other human diseases. [SP=150 Cap=250m]
LoopUp (LOOP) guides H2 rev up 43% and adj EBITDA £12.2m (£3.5m). Expects to exceed FY market expectations. [SP=181 Cap=100m]
Eagle Eye Solutions (EYE) guides FY(June) rev up 21% and adj EBITDA £3.3m (£0.7m). "While new business decision making is likely to continue to be delayed during this period of uncertainty, our sales pipeline continues to grow, and we are engaged in positive discussions across multiple geographies." [SP=182.8 Cap=47m]
Morses Club (MCL) Home Collected Credit issued during first four months of FY is 34% ahead of the covid plan, albeit down 47% on year. Cash collections 21% ahead of covid plan. Borrowing cut to reduced to £12m cf plan of £18.5m - puts co in a strong position to take advantage of any increase in market demand [SP=53.82 Cap=71m]
Symphony Environmental Technologies (SYM) guides H1(June) rev up 21%. Some distributors have experienced severe lockdowns which have delayed growth. Group does not expect to need any additional cash in the next 12 months. "Group is pleased to see growing orders, and indications of a much stronger order book going forward." But no guidance. [SP=13.7 Cap=23m]
Sumo Group (SUMO) £13.7m placing at 180, a 7% disc. Cash is for potential M&A opportunities. [SP=187.9 Cap=285m]
Gresham House (GHE) Trading at least in line with market expectations for FY. AuM up 17% in H1, 10% organic. [SP=633.9 Cap=195m]
PV Crystalox Solar (PVCS) 55p (9% premium) tender offer but only for up to 3.6m shares. 7.3m in issue. Will delist end Sept. [SP=52.2 Cap=4m]
TP Group (TPG) H1(June) trading: no rev figure! Co "well equipped to continue its robust performance in the second half of the year." [SP=7.45 Cap=58m]
Hardide (HDD) guides FY(Sept) rec at least £4.7m, down 8%. Delay of large order from a major oil well operator which has rescheduled the development of a major project to 2021. Co has sufficient cash reserves for the medium to long term based on the current sales projections. [SP=23 Cap=12m]
OptiBiotix Health (OPTI) has extended the terms, territories and products from its distribution agreement with CTC Holding for the sale of CholBiome. [SP=55 Cap=48m]
Loungers (LGRS) has re-opened 75 Lounges and 19 Cosy Clubs (from total 138 and 29 resp.). "As a result of the confidence we have gained from the trading at our re-opened sites to date, we have decided to accelerate our re-opening programme and will have the full estate re-opened by 5 August." Will close 2 outlets though. [SP=115 Cap=118m]
SIMEC Atlantis Energy (SAE) flagship Uskmouth power station conversion project will now be developed in two halves due to lockdown delay. Financial close expected to occur in late Q1 2021 or early Q2 2021. [SP=17.5 Cap=75m]
Mirada (MIRA) FY(Mar) rev up 7%. Pretax $275k (-$3.3m). "Despite the uncertain impact of COVID-19, Mirada's financial position is continuously improving,...these factors have led to an improved commercial performance, with participation in multiple deals, which, combined with the growing pipeline, provides confidence in the Company's ability to secure more contract wins in the coming years." [SP=82 Cap=8m]
Nanoco (NANO) increased fundraise last night to £3.4m, at 17.5p, a 3% discount. [SP=18.14 Cap=52m]

In line: BRK, XAR
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 17-Jul-20
WEY to go, DISH banging its plate.

BigDish (DISH) RNS sounds like a rebuttal to a criticism of its move to monthly fees. Are people doubting this stoke of genius? Co will not be charging restaurants until the SaaS model is further developed. "The Company did not take into account any revenue assumptions in its assessment regarding having adequate funding runway until the end of December this year." Further statement in Sept. Discussions with experienced technology investors with regards to further funding. [SP=1.42 Cap=5m]
Pennant International (PEN) wins contract worth £1.5m initially. Order book scheduled for 2021 totals almost £13.5m. [SP=35.15 Cap=13m]
Adamas Finance Asia (ADAM) £3.1m placing and OO at 25p, a 14% discount. Cash for more investements. Says Asian SME w/o acces to banks have a $2.7trillion funding gap. Well, £3.1m is hardly enough is it? [SP=30 Cap=30m]
Renalytix AI (RENX) $74.3m global offering. ADS offered at $13.50 will list on Nasdaq. [SP=634.42 Cap=377m]
Xpediator (XPD) guides H1(June) trading only marginally behind management's original expectations. Net cash £4.2m after paying deferred consideration. No FY guidance. [SP=22.06 Cap=31m]
ClearStar (CLSU) guides H1(June) rev down 23%. June rev back to Feb level. EBITDA positive in May & June. [SP=30 Cap=11m]
Gattaca (GATC) guides FY(July) Net Fee Income down 22%. Last 3 months stronger than the Board's initial expectations. Net cash £23m (June). Targeting cost savings over £3m PA by H1 2021. [SP=42.45 Cap=14m]
Wey Education (WEY) guides FY(Aug) rev £8m and pretax above market expectations of £0.5m desoute increased marketing. [SP=23.28 Cap=32m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 20-Jul-20


Synairgen (SNG) very positive results from trial of SNG001, inhaled formulation of interferon beta, in hospitalised COVID-19 patients. Further analysis will be conducted. [SP=36.5 Cap=55m]
Gamma Communications (GAMA) H1(June) trading. Guides FY EPS ahead of consensus of 46.5p. [SP=1470 Cap=1396m]
Parity Group (PTY) guides H1(June) rev c. £30m, down 33%, and modest adj pretax profit. Co seeing a return of new sales opportunities, following the severe reduction in early stage opportunities and projects during lockdown. [SP=7.17 Cap=8m]
Tungsten (TUNG) guides FY(Apr) rev up 2% and adj EBITDA broadly in line with market guidance. Trading in the beginning of the new financial year has been positive. [SP=40 Cap=50m]
Angle (AGL) good results from pilot study of Parsortix liquid biopsy for detection of breast cancer. [SP=55 Cap=95m]
Pittards (PTD) H1 sales running at 55% down. Guides significant loss in H1. "Group has adequate resources to manage the likely duration of the COVID19 crisis at these reduced sales levels." [SP=41.8 Cap=6m]
Surface Transforms (SCE) guides H1(June) rev up 55% to £902k. Outlook "on track to reach positive adjusted EBITDA in 2021, report a profit before tax in 2022, and still expects to make further new contract announcements during 2020." [SP=26.7 Cap=41m]
Alpha Growth (ALGW) Fund has seen a significant rise in interest from US registered investment advisors (RIA) and family offices. Next steps involve the RIAs conducting due diligence on the Fund and manager which several have started. [SP=1.87 Cap=4m]
OptiBiotix Health (OPTI) guides H1(June) sales of LPLDL and SlimBiome (I think that is all rev) up 398% to £740k. "We hope to close out one or more agreements within the coming months." [SP=53.14 Cap=47m]
Clean Invest Africa (CIA) delays FY19 accounts to end Sept at the latest. TRading: "Whilst the past few months have been extremely challenging Coaltech is looking forward to the next period with significant optimism due to the substantial and strong pipeline and in addition a developing opportunity to expand beyond coal." [SP=NA Cap=NA]
Bermele (BERM) plans RTO of East Imperial, a Singapore co that designs, develops, formulates, manufactures, distributes and sells small batch blended premium mixers. Shares suspended pending completion. [SP=0.98 Cap=2m]
Reneuron Group (RENE) FY loss in line. Outlook "very encouraged to see the potential of our exosome and iPS cell technologies emerge during the period, with further collaboration agreements expected in the near term to complement the agreements we have already signed with major pharmaceutical/biotechnology companies regarding our exosome programme." [SP=136.75 Cap=44m]

In line: MJH, INS
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 21-Jul-20


Ergomed (ERGO) guides H1(June) rev up 15%, order book up 22% since Jan. Expects FY EBITDA materially ahead of market expectations. [SP=580 Cap=280m]
Ted Baker (TED) last 11 week rev down 55%, ahead of the base case lockdown scenario Net cash £56.7m, ahead of management expectations. [SP=70.6 Cap=130m]
Bidstack (BIDS) guides H1(June) rev £0.275m. Co "confident that it is making material progress in its approach to building a strong foundation on which to grow and create value." Hmm. [SP=4.25 Cap=16m]
Eleco (ELCO) has changed name from Elecosoft. [SP=83.1 Cap=68m]
Bloomsbury (BMY) last 4 months rev up 18%, ahead of the Board's expectations. Lockdown boost IMO. No FY guidance. [SP=200 Cap=158m]
Judges Scientific (JDG) guides H1(June) rev down 18% but orders down 17%. Blames closure of universities, the cancellation of scientific conferences and co's inability to travel. Organic order book 'satisfactory'. Co is in "a robust position to weather the impact of the pandemic." [SP=5260 Cap=330m]
KRM22 (KRM) guides H1(June) ARR (what is that?) £4m, excludes disputed contract with ARR of £0.3m. Confident of meeting FY management expectations. [SP=32 Cap=9m]
Panoply (TPX) guides FY(Mar) rev up 49%, adj EBITDA in line with market expectations. Q1 rev up 60% and adj EBITDA £1.7m (0.5m). Guides FY significantly above market expectations. [SP=75.5 Cap=42m]
Synairgen (SNG) clarifies that yesterday's impressive covid treatment trial result was a phase II. [SP=190 Cap=284m]
GSTechnologies (GST) outline Singapore lockdown hit to subsidiary EMS Wiring Systems. [SP=0.27 Cap=3m]
React (REAT) wins contracts worth c. £350k to rund for 5 weeks from Aug. [SP=1.1 Cap=5m]
Collagen Solutions (COS) now has orders or contracted development milestones, together with revenue already recognised through the first three months of the financial year, worth c. £4.3m (108% of last FY rev). [SP=2.51 Cap=11m]
Kape Technologies (KAPE) guides H1(June) in line. Integration of PIA has advanced ahead of management's projections. Confident of FY rev $120-$123m and adj EBITDA $35-$38m. [SP=194 Cap=308m]

In line: RPS
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 22-Jul-20
Part 1/2

eve Sleep (EVE) guides H1(June) rev down 6% but Q2 was up 25%, ahead of the Board's expectations. U/L EBITDA loss £1.2m down 80%. Cashflow positive. Leaves FY expectations unchanged "but is increasingly confident in the out-turn". [SP=1.66 Cap=5m]
Maestrano (MNO) guides FY rev £885k, down 2% but up 2% at const currency. EBITDA -£227k (-£304k). Confident of continuing growth in FY21. [SP=8.3 Cap=12m]
Iofina (IOF) H1 production flat at 284MT. Guides H1 340-360MT. Refinancing delayed by covid, anticipated it will be completed within the two-month extension recently granted by current senior lender. Hemp: seed sales from the JV through its sales partner have been much lower than expected due to covid and a lack of a comprehensive USA hemp crop insurance. [SP=16.1 Cap=31m]
BigDish (DISH) re SP rise - Pizza Hut have agreed to join BigDish but reminds us that DISH is not charging now. [SP=2.17 Cap=8m]
Scancell (SCLP) £9m placing and OO at 5.5p (20% disc) and £6m convertibles with a low strike of 6.2p. Cash needed for drug trials and to continue initial COVID-19 vaccine development until non-dilutive funding or third-party partnering transaction. [SP=6.85 Cap=32m]
Lamprell (LAM) guides H1(June) EBITDA broadly breakeven. Backlog $580m (Dec: $470m). Net cash up. Confident. [SP=22.4 Cap=77m]
Barkby (BARK) op update. Gets £1m covid loan. £1.9m income from completion of Hastings site expected by end of August. [SP=21.5 Cap=28m]
Avacta (AVCT) begins work with Gov't CONDOR programme to evaluate and validate the high throughput COVID-19 bead-assisted mass spectrometry laboratory assay developed with Adeptrix. Up to 1,000 nasopharyngeal swab or saliva samples per day can be analysed by a single technician. [SP=142.5 Cap=355m]
Diaceutics (DXRX) wins $1.27m contract [SP=165 Cap=139m]
Zoetic (ZOE) partnership with cannabinoid research experts GVB Biopharma, represents the first large scale commercial hemp study. Will terminate Colorado greenhouse facility lease due to changed business model. [SP=9.48 Cap=18m]
Mears (MEAR) guides H1(June) rev-cont down 8%. Pretax-cont (before the amortisation of acquisition intangibles) -£6m (+£16.7m). Co expects to see a recovery in activity levels in H2. Continues to look at disposals to cut debt. [SP=NA Cap=NA]
Quixant (QXT) H1 rev down but no figs! Net cash $14.2m down $1.9m in half. [SP=112.5 Cap=75m]
Cloudcall (CALL) guides H1(June) rev up 11% to £5.8m. Cash at hand £8.4m. Cash burn cut to £250k a month. "Since May, as homeworking became more established, sales numbers have steadily improved - largely driven by the recruitment sector...By early June, the upturn had accelerated, and we began receiving enquiries from more sizeable organisations." [SP=71.9 Cap=28m]

In line: ANX
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 22-Jul-20
Part 2/2

Boku (BOKU) guides H1(June) rev at least $24.7m ($23.5m). Underlying Payments revenue up 13.5% but Identity division rev down. Guides FY adj EBITDA at least in line with expectations, up at least 65%. [SP=89 Cap=250m]
Mediclinic (MDC) vague AGM stmt - continued improvement in operational performance in June. Mediclinic Southern Africa rev down 12%. [SP=267.8 Cap=1982m]
Drumz (DRUM) name change from Energiser Investments. [SP=NA Cap=NA]
Tristel (TSTL) guides FY(june) ahead of market expectations with rev up 21% and adj pretax at least 21% up. Has applied for Canadian registration of the Duo foam product for ophthalmology. USA lockdown has prevented two important parts of the FDA submission from progressing in H2. "To maintain the momentum that has built over the past four months we need hospitals, especially in the UK, to return to pre-COVID-19 levels of patient throughput. Whilst we believe that hospitals will revert to more normal levels of activity, we cannot be certain as to timing." [SP=424 Cap=192m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 23-Jul-20
Part 1/2. Slow RNS feeds.

XLMedia (XLM) guides H1 rev $27.5m ($42.5m), EBITDA c. $3.5m ($18.6m). Blames Google deranking, covid and ending media buying operations. Deranking around $1m pcm hit. Outllok "prioritising removing the penalties imposed by Google on some of its premium sites. Combined with recent encouraging signs of increased activity in Sports and Personal Finance, this would provide an increasing level of confidence in the Company's ability to grow revenue and profit in 2021 and beyond." [SP=24.6 Cap=46m]
Symphony Environmental Technologies (SYM) positive in vitro antiviral test results for d2p antimicrobial masterbatch technology. Used Bovine Coronavirus - why not covid-19? [SP=29.8 Cap=51m]
Midatech Pharma (MTPH) ends formal sale process after no proposals. Still exploring options for extracting value from its technologies and providing working capital. Evaluating early stage proposals including the potential acquisition of certain assets or an RTO. [SP=35.55 Cap=14m]
Gear4Music (G4M) Q1 rev up 68%, ahead of mgmt exp. [SP=484.11 Cap=101m]
NAHL Group (NAH) guides H1(June) rev down 21%. U/L earnings £1.0- 1.2m (£3.4m). Personal Injury enquiry volumes now recovered to 50-60% of prior year. Conveyancing recovered quickly during June. Noticeable slowing of new enquiries in Critical Care div. Not breached covenants and new covenants provide 'reasonable' levels of headroom. [SP=38.62 Cap=18m]
Attraqt Group (ATQT) guides H1(June) broadly in line with the Board's expectations. Significant increase in usage volume but new bookings slowed. [SP=28.5 Cap=51m]
Immunodiagnostic Systems (IDH) Q1(June) rev down 39% due to postponements of routine testing. July rev down <20%. [SP=244.99 Cap=71m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian